PGR
65
2
EL
25
4
UNP
52
7
GE
67
2
VTR
47
-7
SE
61
-4
FDX
43
3
INTC
33
-2
BBY
46
10
DNB
82
4
FSLR
54
7
ZION
65
2
LH
43
-2
TSCO
49
5
URBN
56
14
CAH
48
-5
HD
57
2
NWS
66
-3
NEE
50
-5
CSCO
67
4
PGR
65
2
EL
25
4
UNP
52
7
GE
67
2
VTR
47
-7
SE
61
-4
FDX
43
3
INTC
33
-2
BBY
46
10
DNB
82
4
FSLR
54
7
ZION
65
2
LH
43
-2
TSCO
49
5
URBN
56
14
CAH
48
-5
HD
57
2
NWS
66
-3
NEE
50
-5
CSCO
67
4
Financhill
Back

Tekla Healthcare Opportunities Fund Vs. VanEck Pharmaceutical ETF Industry Stock Comparison

Sell
14

THQ
Tekla Healthcare Opportunities Fund

Last Price:
20.26
Seasonality Move:
0.53%
Sell
46

PPH
VanEck Pharmaceutical ETF

Last Price:
88.81
Seasonality Move:
5.66%
Sell
14
Tekla Healthcare Opportunities Fund (THQ) is a Sell

Is Tekla Healthcare Opportunities Fund a Buy, Sell or Hold?

  • The current Tekla Healthcare Opportunities Fund [THQ] share price is $19.83. The Score for THQ is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
  • THQ is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
46
VanEck Pharmaceutical ETF (PPH) is a Sell

Is VanEck Pharmaceutical ETF a Buy, Sell or Hold?

  • The current VanEck Pharmaceutical ETF [PPH] share price is $88.58. The Score for PPH is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • PPH is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

THQ Stock Price Chart

What is Tekla Healthcare Opportunities Fund's stock price today?

  • The Tekla Healthcare Opportunities Fund share price today is $19.83
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and THQ is experiencing slight buying pressure.

PPH Stock Price Chart

What is VanEck Pharmaceutical ETF's stock price today?

  • The VanEck Pharmaceutical ETF share price today is $88.58
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PPH is experiencing slight selling pressure.

THQ Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.53 Sell
Relative Strength Index (14 RSI): 36.08 Sell
Chaikin Money Flow: 92477 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (19.94 - 21.6) Sell
Bollinger Bands (100): (20.7 - 22.04) Sell

PPH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.55 Sell
Relative Strength Index (14 RSI): 39.12 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (88.19 - 92.53) Sell
Bollinger Bands (100): (90.84 - 96.78) Sell

THQ Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 19.72 Buy
20-day SMA: 20.51 Sell
50-day SMA: 21.39 Sell
200-day SMA: 20.62 Sell
8-day EMA: 19.89 Sell
20-day EMA: 20.43 Sell
50-day EMA: 21.01 Sell
200-day EMA: 20.57 Sell

PPH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 87.71 Buy
20-day SMA: 89.7 Sell
50-day SMA: 92.71 Sell
200-day SMA: 91.61 Sell
8-day EMA: 88.14 Buy
20-day EMA: 89.52 Sell
50-day EMA: 91.71 Sell
200-day EMA: 90.75 Sell

Tekla Healthcare Opportunities Fund Earnings Growth & THQ Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

VanEck Pharmaceutical ETF Earnings Growth & PPH Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Tekla Healthcare Opportunities Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

VanEck Pharmaceutical ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):